ConvaTec Group (CTEC) Earns “Buy” Rating from Jefferies Financial Group
Jefferies Financial Group restated their buy rating on shares of ConvaTec Group (LON:CTEC) in a research note released on Friday, Digital Look reports. They currently have a GBX 145 ($1.89) price target on the stock.
Several other equities research analysts have also recently issued reports on the stock. Peel Hunt raised shares of ConvaTec Group to a buy rating and lifted their target price for the stock from GBX 150 ($1.96) to GBX 230 ($3.01) in a research note on Monday, March 25th. Numis Securities reaffirmed a buy rating and set a GBX 220 ($2.87) target price on shares of ConvaTec Group in a research note on Monday, January 21st. JPMorgan Chase & Co. reaffirmed a neutral rating and set a GBX 135 ($1.76) target price (down previously from GBX 192 ($2.51)) on shares of ConvaTec Group in a research note on Monday, February 18th. UBS Group lowered their target price on shares of ConvaTec Group from GBX 150 ($1.96) to GBX 120 ($1.57) and set a neutral rating on the stock in a research note on Tuesday, February 19th. Finally, Goldman Sachs Group lowered their target price on shares of ConvaTec Group from GBX 165 ($2.16) to GBX 160 ($2.09) and set a neutral rating on the stock in a research note on Friday, January 18th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company. ConvaTec Group has a consensus rating of Hold and a consensus target price of GBX 153.90 ($2.01).
Shares of CTEC opened at GBX 143.35 ($1.87) on Friday. ConvaTec Group has a 52-week low of GBX 113.25 ($1.48) and a 52-week high of GBX 240.50 ($3.14). The company has a debt-to-equity ratio of 101.69, a quick ratio of 1.72 and a current ratio of 2.73. The firm has a market cap of $2.81 billion and a price-to-earnings ratio of 13.03.
In other news, insider Rick Anderson purchased 55,500 shares of the stock in a transaction dated Monday, March 25th. The shares were purchased at an average price of GBX 137 ($1.79) per share, with a total value of £76,035 ($99,353.19).
ConvaTec Group Company Profile
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Featured Story: Should You Consider an Index Fund?
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.